 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aligos Therapeutics
ALGS
|
30.2 |
$ 8.64 |
8.07 % |
$ 85.4 M |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
131 |
$ 3.66 |
-1.48 % |
$ 8.81 B |
Australia |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
Applied Therapeutics
APLT
|
54.1 |
- |
- |
$ 8.42 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
1.73 |
$ 21.36 |
4.86 % |
$ 998 M |
USA |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
1.42 |
$ 1.47 |
5.0 % |
$ 378 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 2.92 |
- |
$ 4.81 M |
Israel |
 |
Aquestive Therapeutics
AQST
|
10.5 |
$ 4.19 |
2.7 % |
$ 448 M |
USA |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 |
$ 24.12 |
-0.37 % |
$ 3.07 B |
USA |
 |
AIkido Pharma
AIKI
|
0.935 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Celldex Therapeutics
CLDX
|
1.32 K |
$ 32.59 |
1.09 % |
$ 2.16 B |
USA |
 |
Autolus Therapeutics plc
AUTL
|
4.27 |
$ 1.47 |
-1.34 % |
$ 391 M |
Britain |
 |
Cidara Therapeutics
CDTX
|
116 |
- |
- |
$ 1.41 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
2.17 |
- |
- |
$ 96.9 B |
Britain |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Esperion Therapeutics
ESPR
|
1.39 |
$ 2.22 |
2.3 % |
$ 461 M |
USA |
 |
Evogene Ltd.
EVGN
|
71.3 |
$ 0.82 |
1.13 % |
$ 27.9 M |
Israel |
 |
Baudax Bio
BXRX
|
0.614 |
- |
0.59 % |
$ 63 K |
USA |
 |
Cabaletta Bio
CABA
|
50.3 M |
$ 3.2 |
2.24 % |
$ 322 M |
USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 |
- |
- |
$ 2.17 B |
USA |
 |
CymaBay Therapeutics
CBAY
|
110 |
- |
- |
$ 3.45 B |
USA |